Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

The Food and Drug Administration, under the Department of Health and Human Services, is offering a funding opportunity through the Health Equity Innovation Award to support innovative research aimed at strengthening minority health and advancing health equity. This U01 award specifically targets projects that enhance equity in clinical research by promoting diversity in clinical trial participation, improving the availability and quality of health data for underrepresented populations—including those defined by race, ethnicity, age, disability, and geographic location—and amplifying the voices of diverse patients to better understand their perspectives, preferences, and unmet health needs. The initiative seeks to bridge longstanding gaps in health outcomes by ensuring research reflects the full spectrum of the U.S. population. This opportunity is designated as a forecast and does not allow clinical trials. Proposals must align with the goal of generating equitable health solutions without conducting clinical interventions. The funding opportunity was posted on August 14, 2024, and inquiries can be directed to Terrin Brown, the designated point of contact, via email or phone. While no specific geographic or organizational set-asides are indicated, applicants are encouraged to engage communities historically excluded from research and to develop scalable, evidence-based strategies that contribute to lasting improvements in health equity across the nation.